FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Collections Drugs and Devices, 1940-1963 ✖Remove constraint Collections: Drugs and Devices, 1940-1963 Titles 3921. Misbranding of methamphetamine hydrochloride tablets, pentobarbital sodium capsules, Tricombisul tablets, thyroid tablets, and Amytal Sodium ( capsules. U. S. v. Andrew J. Kennedy (Kennedy Drugs), and Paul J. Argust. Pleas of guilty. Fine of $400 against Defendant Kennedy and $200 against Defendant Argust. ✖Remove constraint Titles: 3921. Misbranding of methamphetamine hydrochloride tablets, pentobarbital sodium capsules, Tricombisul tablets, thyroid tablets, and Amytal Sodium ( capsules. U. S. v. Andrew J. Kennedy (Kennedy Drugs), and Paul J. Argust. Pleas of guilty. Fine of $400 against Defendant Kennedy and $200 against Defendant Argust. Issue Dates August 1953 ✖Remove constraint Issue Dates: August 1953

Refine by:

  • 3921. Misbranding of methamphetamine hydrochloride tablets, pentobarbital sodium capsules, Tricombisul tablets, thyroid tablets, and Amytal Sodium ( capsules. U. S. v. Andrew J. Kennedy (Kennedy Drugs), and Paul J. Argust. Pleas of guilty. Fine of $400 against Defendant Kennedy and $200 against Defendant Argust.1